Does methotrexate actually stunt growth in children?
Methotrexate can affect growth in some pediatric settings, but the overall risk depends on why it’s being used and how dosing is managed. In children treated for inflammatory conditions, the biggest threat to normal growth is often the underlying disease itself (for example, uncontrolled inflammation), not methotrexate alone.
Clinical experience and prescribing information commonly describe monitoring height and growth during treatment, because methotrexate can contribute to side effects such as nausea, reduced appetite, or inflammation control changes that indirectly affect growth.
What about the common fear: “Methotrexate stops kids from growing”?
The idea that methotrexate permanently stops growth is not accurate as a blanket statement. Many children treated with methotrexate maintain normal growth trajectories, especially when the condition is well controlled and the drug is dosed appropriately with regular monitoring.
That said, some children can show slowed growth, and clinicians typically watch for growth delay so they can adjust treatment if needed.
Why growth problems can happen even if methotrexate isn’t the only cause
Growth delay in children on methotrexate may relate to:
- The underlying illness (chronic inflammatory disease can reduce growth)
- Other medications used alongside methotrexate, especially corticosteroids, which are a well-known cause of growth suppression
- Nutritional issues (less intake due to side effects)
- Ongoing disease activity (if inflammation isn’t fully controlled, growth can lag)
How doctors monitor growth while a child is on methotrexate
Clinicians commonly track:
- Height and weight over time (growth curves)
- Puberty development
- Symptoms and markers of disease control
- Possible medication side effects that could affect nutrition or tolerance
If growth slows, prescribers may reassess disease control, nutrition, and whether other drugs (like steroids) are contributing.
When to ask the prescriber about growth delay
Parents and patients should ask about growth if there is:
- A noticeable drop in growth rate compared with prior years
- Height percentile falling over time
- Delays in puberty compared with peers
- Ongoing symptoms suggesting poor disease control or medication intolerance
If you share the child’s age, the condition being treated, and whether methotrexate is used with steroids, I can help you frame the most relevant questions for the prescribing clinician.
Sources cited
No provided sources.